Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA Grants Fast Track Designation to CTI BioPharma's Pacritinib, a Novel JAK2 Inhibitor for the Treatment of Myelofibrosis
Yahoo
Thursday, August 7, 2014 - 9:00am
tags:
pacritinib, FDA, CTI BioPharma, fast track, myelofibrosis
Isis Pharmaceuticals Posts Narrower-Than-Expected Q2 Loss
Yahoo/Zacks.com
Thursday, August 7, 2014 - 8:50am
tags:
Isis Pharmaceuticals, earnings
US FDA tweaks requirements for 12-year biologics exclusivity
Biopharma-Reporter
Thursday, August 7, 2014 - 8:49am
tags:
FDA, exclusivity, biologics
UCB hops on pharma's spinoff wagon with potential $2B sale of generics business
Fierce Pharma
Thursday, August 7, 2014 - 8:32am
tags:
generics, UCB Pharmaceuticals, M&A, Kremers Urban Pharmaceuticals
Sanofi Licenses Immune Design's GLAAS Platform to Explore Novel Approach to Treat Food Allergy
Yahoo
Thursday, August 7, 2014 - 8:18am
tags:
GLAAS plantform, Immune Design, Sanofi, food allergies
Mylan Posts Lower Q2 Earnings, Narrows Full-Year Outlook
Benzinga
Thursday, August 7, 2014 - 8:17am
tags:
Mylan Labs, earnings
Novo Nordisk Profit Beats Estimates as Victoza Sales Rise
Bloomberg
Thursday, August 7, 2014 - 8:16am
tags:
Novo Nordisk, earnings
Most popular news headlines for Wednesday, August 6 2014
CP Wire
Thursday, August 7, 2014 - 7:56am
tags:
CVS Caremark, Express Scripts, Sanofi, Regeneron, Amgen, Ian Read, Physician Payment Sunshine Act
Proxy adviser ISS backs call for Allergan holder meeting
Marketwatch
Wednesday, August 6, 2014 - 9:43pm
tags:
Allergan, Valeant Pharmaceuticals, M&A
FDA approves The Medicines Co's acute skin infection drug
Yahoo/Reuters
Wednesday, August 6, 2014 - 9:40pm
tags:
FDA, The Medicines Company, Orbactiv, antibiotic resistance, antibiotics
Pfizer to pay $35 mln to U.S. states to settle Rapamune claims
Yahoo/Reuters
Wednesday, August 6, 2014 - 6:58pm
tags:
Rapamune, Pfizer, off-label
Docs Urge CMS to Postpone Deadline for ‘Sunshine’ Data Disclosures
WSJ Online
Wednesday, August 6, 2014 - 11:07am
tags:
Physician Payment Sunshine Act, physicians
As race to market intensifies, how expectant are cardiologists for PCSK9 inhibitor class?
First Word Pharma
Wednesday, August 6, 2014 - 10:11am
tags:
cardiologists, physicians, PCSK9 inhibitors, Sanofi, Regeneron, Amgen, evolocumab, alirocumab
Ian Read: LinkedIn and Locked on
Drugwonks
Wednesday, August 6, 2014 - 10:02am
tags:
Pfizer, Pharma CEOs, Ian Read, pharma industry, social media
Clot Busters For Stroke Gain More Support
Forbes
Wednesday, August 6, 2014 - 9:58am
tags:
Activase, Roche, stroke, thrombolysis
Which Drugs are CVS Caremark and Express Scripts Restricting? Look Here
WSJ Online
Wednesday, August 6, 2014 - 9:51am
tags:
Express Scripts, PBMs, CVS Caremark
Acadia On Track With Pimavanserin Development Program
Yahoo/Zacks.com
Wednesday, August 6, 2014 - 9:50am
tags:
Acadia, pimavanserin, earnings, Parkinson's Disease Psychosis
Cubist Pharma recalls some vials of antibiotic Cubicin
Yahoo/Reuters
Wednesday, August 6, 2014 - 9:41am
tags:
antibiotics, recalls, Cubist Pharma, Cubicin
Why Is Allergan Up 43% This Year?
Bidness Etc
Wednesday, August 6, 2014 - 8:19am
tags:
Allergan, Valeant Pharmaceuticals
Teva eyes 'hard switch' to hit Copaxone goals if the soft sell isn't enough
Fierce Pharma Marketing
Wednesday, August 6, 2014 - 8:14am
tags:
Teva Pharmaceutical, MS, multiple sclerosis, Copaxone

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.